化学療法

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global lung cancer therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global lung cancer therapeutics market 2017 - 2021 ($ million)
4.2 Therapy Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Therapy
6.1 Market segments
Exhibit 30: Chart on Therapy - Market share 2022-2027 (%)
Exhibit 31: Data Table on Therapy - Market share 2022-2027 (%)
6.2 Comparison by Therapy
Exhibit 32: Chart on Comparison by Therapy
Exhibit 33: Data Table on Comparison by Therapy
6.3 Targeted therapy - Market size and forecast 2022-2027
Exhibit 34: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
6.4 Immunotherapy - Market size and forecast 2022-2027
Exhibit 38: Chart on Immunotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Immunotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Immunotherapy - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Immunotherapy - Year-over-year growth 2022-2027 (%)
6.5 Chemotherapy - Market size and forecast 2022-2027
Exhibit 42: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Therapy
Exhibit 46: Market opportunity by Therapy ($ million)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 47: Chart on Type - Market share 2022-2027 (%)
Exhibit 48: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 49: Chart on Comparison by Type
Exhibit 50: Data Table on Comparison by Type
7.3 NSCLC - Market size and forecast 2022-2027
Exhibit 51: Chart on NSCLC - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on NSCLC - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on NSCLC - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on NSCLC - Year-over-year growth 2022-2027 (%)
7.4 SCLC - Market size and forecast 2022-2027
Exhibit 55: Chart on SCLC - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on SCLC - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on SCLC - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on SCLC - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 59: Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 63: Chart on Geographic comparison
Exhibit 64: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Canada - Market size and forecast 2022-2027
Exhibit 89: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 France - Market size and forecast 2022-2027
Exhibit 97: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on France - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 101: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 102: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 104: Overview on factors of disruption
11.4 Industry risks
Exhibit 105: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 106: Vendors covered
12.2 Market positioning of vendors
Exhibit 107: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 108: AbbVie Inc. - Overview
Exhibit 109: AbbVie Inc. - Product / Service
Exhibit 110: AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 111: Amgen Inc. - Overview
Exhibit 112: Amgen Inc. - Product / Service
Exhibit 113: Amgen Inc. - Key offerings
12.5 Astellas Pharma Inc.
Exhibit 114: Astellas Pharma Inc. - Overview
Exhibit 115: Astellas Pharma Inc. - Product / Service
Exhibit 116: Astellas Pharma Inc. - Key news
Exhibit 117: Astellas Pharma Inc. - Key offerings
12.6 AstraZeneca Plc
Exhibit 118: AstraZeneca Plc - Overview
Exhibit 119: AstraZeneca Plc - Product / Service
Exhibit 120: AstraZeneca Plc - Key news
Exhibit 121: AstraZeneca Plc - Key offerings
12.7 Boehringer Ingelheim International GmbH
Exhibit 122: Boehringer Ingelheim International GmbH - Overview
Exhibit 123: Boehringer Ingelheim International GmbH - Business segments
Exhibit 124: Boehringer Ingelheim International GmbH - Key news
Exhibit 125: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 126: Boehringer Ingelheim International GmbH - Segment focus
12.8 Bristol Myers Squibb Co.
Exhibit 127: Bristol Myers Squibb Co. - Overview
Exhibit 128: Bristol Myers Squibb Co. - Product / Service
Exhibit 129: Bristol Myers Squibb Co. - Key offerings
12.9 Daiichi Sankyo Co. Ltd.
Exhibit 130: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 131: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 132: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 133: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 134: Daiichi Sankyo Co. Ltd. - Segment focus
12.10 Eli Lilly and Co.
Exhibit 135: Eli Lilly and Co. - Overview
Exhibit 136: Eli Lilly and Co. - Product / Service
Exhibit 137: Eli Lilly and Co. - Key offerings
12.11 F. Hoffmann La Roche Ltd.
Exhibit 138: F. Hoffmann La Roche Ltd. - Overview
Exhibit 139: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 140: F. Hoffmann La Roche Ltd. - Key news
Exhibit 141: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 142: F. Hoffmann La Roche Ltd. - Segment focus
12.12 GlaxoSmithKline Plc
Exhibit 143: GlaxoSmithKline Plc - Overview
Exhibit 144: GlaxoSmithKline Plc - Business segments
Exhibit 145: GlaxoSmithKline Plc - Key offerings
Exhibit 146: GlaxoSmithKline Plc - Segment focus
12.13 Merck and Co. Inc.
Exhibit 147: Merck and Co. Inc. - Overview
Exhibit 148: Merck and Co. Inc. - Business segments
Exhibit 149: Merck and Co. Inc. - Key news
Exhibit 150: Merck and Co. Inc. - Key offerings
Exhibit 151: Merck and Co. Inc. - Segment focus
12.14 Novartis AG
Exhibit 152: Novartis AG - Overview
Exhibit 153: Novartis AG - Business segments
Exhibit 154: Novartis AG - Key offerings
Exhibit 155: Novartis AG - Segment focus
12.15 Pfizer Inc.
Exhibit 156: Pfizer Inc. - Overview
Exhibit 157: Pfizer Inc. - Product / Service
Exhibit 158: Pfizer Inc. - Key news
Exhibit 159: Pfizer Inc. - Key offerings
12.16 Sanofi SA
Exhibit 160: Sanofi SA - Overview
Exhibit 161: Sanofi SA - Business segments
Exhibit 162: Sanofi SA - Key news
Exhibit 163: Sanofi SA - Key offerings
Exhibit 164: Sanofi SA - Segment focus
12.17 Takeda Pharmaceutical Co. Ltd.
Exhibit 165: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 166: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 167: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 168: Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 169: Inclusions checklist
Exhibit 170: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 171: Currency conversion rates for US$
13.4 Research methodology
Exhibit 172: Research methodology
Exhibit 173: Validation techniques employed for market sizing
Exhibit 174: Information sources
13.5 List of abbreviations
Exhibit 175: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global lung cancer therapeutics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Therapy - Market share 2022-2027 (%)
Exhibits31: Data Table on Therapy - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapy
Exhibits33: Data Table on Comparison by Therapy
Exhibits34: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Immunotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Immunotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Immunotherapy - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Immunotherapy - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Therapy ($ million)
Exhibits47: Chart on Type - Market share 2022-2027 (%)
Exhibits48: Data Table on Type - Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by Type
Exhibits50: Data Table on Comparison by Type
Exhibits51: Chart on NSCLC - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on NSCLC - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on NSCLC - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on NSCLC - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on SCLC - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on SCLC - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on SCLC - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on SCLC - Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Type ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: AbbVie Inc. - Overview
Exhibits109: AbbVie Inc. - Product / Service
Exhibits110: AbbVie Inc. - Key offerings
Exhibits111: Amgen Inc. - Overview
Exhibits112: Amgen Inc. - Product / Service
Exhibits113: Amgen Inc. - Key offerings
Exhibits114: Astellas Pharma Inc. - Overview
Exhibits115: Astellas Pharma Inc. - Product / Service
Exhibits116: Astellas Pharma Inc. - Key news
Exhibits117: Astellas Pharma Inc. - Key offerings
Exhibits118: AstraZeneca Plc - Overview
Exhibits119: AstraZeneca Plc - Product / Service
Exhibits120: AstraZeneca Plc - Key news
Exhibits121: AstraZeneca Plc - Key offerings
Exhibits122: Boehringer Ingelheim International GmbH - Overview
Exhibits123: Boehringer Ingelheim International GmbH - Business segments
Exhibits124: Boehringer Ingelheim International GmbH - Key news
Exhibits125: Boehringer Ingelheim International GmbH - Key offerings
Exhibits126: Boehringer Ingelheim International GmbH - Segment focus
Exhibits127: Bristol Myers Squibb Co. - Overview
Exhibits128: Bristol Myers Squibb Co. - Product / Service
Exhibits129: Bristol Myers Squibb Co. - Key offerings
Exhibits130: Daiichi Sankyo Co. Ltd. - Overview
Exhibits131: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits132: Daiichi Sankyo Co. Ltd. - Key news
Exhibits133: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits134: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits135: Eli Lilly and Co. - Overview
Exhibits136: Eli Lilly and Co. - Product / Service
Exhibits137: Eli Lilly and Co. - Key offerings
Exhibits138: F. Hoffmann La Roche Ltd. - Overview
Exhibits139: F. Hoffmann La Roche Ltd. - Business segments
Exhibits140: F. Hoffmann La Roche Ltd. - Key news
Exhibits141: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits142: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits143: GlaxoSmithKline Plc - Overview
Exhibits144: GlaxoSmithKline Plc - Business segments
Exhibits145: GlaxoSmithKline Plc - Key offerings
Exhibits146: GlaxoSmithKline Plc - Segment focus
Exhibits147: Merck and Co. Inc. - Overview
Exhibits148: Merck and Co. Inc. - Business segments
Exhibits149: Merck and Co. Inc. - Key news
Exhibits150: Merck and Co. Inc. - Key offerings
Exhibits151: Merck and Co. Inc. - Segment focus
Exhibits152: Novartis AG - Overview
Exhibits153: Novartis AG - Business segments
Exhibits154: Novartis AG - Key offerings
Exhibits155: Novartis AG - Segment focus
Exhibits156: Pfizer Inc. - Overview
Exhibits157: Pfizer Inc. - Product / Service
Exhibits158: Pfizer Inc. - Key news
Exhibits159: Pfizer Inc. - Key offerings
Exhibits160: Sanofi SA - Overview
Exhibits161: Sanofi SA - Business segments
Exhibits162: Sanofi SA - Key news
Exhibits163: Sanofi SA - Key offerings
Exhibits164: Sanofi SA - Segment focus
Exhibits165: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits166: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits167: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits168: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits169: Inclusions checklist
Exhibits170: Exclusions checklist
Exhibits171: Currency conversion rates for US$
Exhibits172: Research methodology
Exhibits173: Validation techniques employed for market sizing
Exhibits174: Information sources
Exhibits175: List of abbreviations